NGN BioMed Opportunity II, L.P. Announces Filing of Early Warning Report

Stamford, Connecticut--(Newsfile Corp. - November 12, 2020) - As required by applicable securities laws, NGN BioMed Opportunity II, L.P. ("NGN") announces that, as a result of the completion of a recent private placement of common shares by Zenith Capital Corp. ("Company"), NGN holds less than 10% of the issued and outstanding common shares of the Company. Prior to the completion of the private placement by the Company, NGN held 13,142,692 common shares, 137,500 common share purchase warrants...

2020-11-12 10:51 AM EST